Cell Therapeutics Inc. (Nasdaq and MTA: CTIC) (the "Company") today announced that it had received a Complete Response Letter from the U.S. Food and Drug Administration (the "FDA") regarding its New Drug Application ("NDA") for Pixuvri(TM) (pixantrone dimaleate) for relapsed or refractory aggre ...

guest published in:04-09   reply:0   view:132    last updated:04-09 14:22( guest )

Q: I was under the impression that an alkaline vegetarian diet was the best diet for all cancer patients. However I just read in Dr. Robert Jay Rowen's book that "solid" tumors like prostate breast lung colon and stomach are best served by an alkaline diet while "soft" tumors like lymphomas leu ...

guest published in:04-07   reply:0   view:25    last updated:04-07 03:14( guest )

von Willebrand factor (VWF) is an essential mediator of platelet adhesion to the vessel wall but little is known about its role in megakaryocytopoiesis. VWF and its platelet receptor glycoprotein Ib (GPIb) are both expressed during megakaryocyte (MK) maturation. This study was designed to evalu ...

guest published in:04-07   reply:0   view:162    last updated:04-07 14:10( guest )

Related ArticlesPrevalence of hyperkalemia among hemodialysis patients in Egypt.Ren Fail. 2009;31(10):891-8Authors: Khedr E Abdelwhab S El-Sharkay M Ali M El Said KINTRODUCTION: Hyperkalemia is a frequent problem in patients with end stage renal disease (ESRD) on maintenance hemodialysis and is ...

guest published in:03-31   reply:0   view:250    last updated:03-31 19:11( guest )

Targeting the tumor microenvironment and angiogenesis is a novel lymphoma therapeutic strategy. The authors report safety activity and angiogenic profiling results with the rituximab and thalidomide plus prednisone etoposide procarbazine and cyclophosphamide (RT-PEPC) regimen in patients with r ...

guest published in:03-17   reply:0   view:134    last updated:03-17 02:28( guest )

author:admin    comment:0   view:136   userful 1

Diabetes Care published online the results of the Novo Nordisk LEAD 6 extension study which evaluated the efficacy and safety of switching from exenatide which is taken twice a day to once-daily Victoza . Results show that when added to oral antidiabetes drugs patients who switched from exenati ...

author:admin    comment:0   view:120   userful 1

BLADE STAFF Dr. John McBride doesn't need a lab test to tell him a large number of patients filling the waiting room at Franklin Park Pediatrics have swine flu. He knows they do. "This really is like a bad bad cold with fever and achiness and the vast majority of people just need Motrin and flu ...

author:admin    comment:0   view:126   userful 1

Research presented at the 2009 American College of Rheumatology meeting finds program initiates lifestyle changesAccording to a new study by Hospital for Special Surgery investigators presented at the American College of Rheumatology meeting on October 21 in Philadelphia most lupus patients are ...

author:admin    comment:0   view:87   userful 1

New data show patients with chronic low back pain on Cymbalta(R) (duloxetine HCl) maintained reductions in pain for 41 weeks.(1) In patients who initially responded to duloxetine this maintenance of pain reduction was accompanied by further reduction in pain that was statistically significant a ...

author:admin    comment:0   view:60   userful 1

Recent research to block the effects of endothelin a powerful substance that constricts blood vessels and stimulates cell growth has led to successful treatment of pulmonary arterial hypertension and provides hope for treating other chronic diseases. The usefulness of the new drugs to treat con ...